Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma
Clinical trial NCT04944914 · RECRUITING
Trial details
- NCT number
- NCT04944914
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2027-06-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.